GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.Colton Jones, Sukeshi Patel Arora, Elvis Obomanu et al.|Journal of Clinical Oncology|2026Cited by 3
Abstract PD8-05: A Retrospective Cohort Study on Mitigating Chemotherapy Side Effects in Breast Cancer Patients: The Role of GLP-1 AgonistsE. Obomanu, C. Dourado, Muluken Megiso et al.|Clinical Cancer Research|2026Cited by 1
Optimizing Nutritional Support in Advanced Non-Small Cell Lung Cancer: Evidence and Controversies in Oral, Enteral, and Parenteral ApproachesE. Obomanu, Zachary Cohn, C. Ugwu et al.|Nutrition and Cancer|2026Cited by 1
One-year outcomes of daratumumab-based vs. non-daratumumab regimens in AL amyloidosis: A propensity-matched real-world studyChidiebube Ugwu, Alankrita Taneja, Muluken Megiso et al.|Blood|2025Cited by 0
Timing of Tyrosine Kinase Inhibitor Switching in Chronic Myeloid Leukemia: A Comparative Analysis of Early Versus Late StrategiesChidiebube J. Ugwu, Alankrita Taneja, Tarfa Verinumbe et al.|Clinical Lymphoma Myeloma & Leukemia|2026Cited by 0